
STIM Stock Analysis
Neuronetics Inc
HEALTHCARE
MEDICAL DEVICES
Performance Overview
Trailing adjusted-close returns as of 2026-07-29. Benchmark is SPY.
YTD Return
1-Year Return
3-Year Return
5-Year Return
Returns are calculated from adjusted close prices and may differ from broker or research-site totals depending on data source, dividend handling, benchmark choice, and latest available trading date.
Legacy Screening Checks
This page uses cached SQL data from the latest StockValueFinder scan, so it loads fast without hitting Alpha Vantage on every page view.
Looks for positive and improving earnings per share.
Looks for strong return on invested capital.
Checks whether operating income comfortably covers interest expense.
Checks whether free cash flow could pay down long-term debt quickly.
Checks whether valuation is reasonable under the current rule set.
Uses 20-day, 50-day, and 200-day moving averages for entry timing context.
Cached Technical Data
Moving average values from the latest stored scan.
Latest Published Stock Research
Research generated: October 23, 2026
STIM Stock Analysis: Why Neuronetics Inc Scored 43% in Stock Value Finder
Neuronetics Inc (STIM): A Detailed Educational Stock Research Review
Overview of Neuronetics Inc (STIM)
This is an educational stock research review of Neuronetics Inc (STIM), a healthcare company operating in the medical devices industry. The purpose of this article is to help readers understand how to evaluate key financial metrics when analyzing a stock, using STIM as a case study. This review is based solely on the supplied facts from StockValueFinder.com and does not include personal opinions, predictions, or financial advice.
Neuronetics Inc is a company that develops, markets, and sells medical devices for mental health treatment. While the specific products are not detailed in the supplied facts, the company operates in a specialized segment of the healthcare sector, which often requires significant research and development investment. As of the most recent data, STIM has a market price of $2.11 per share and carries a StockValueFinder score of 43%, resulting in an "AVOID" rating.
This article will walk through each key financial metric used in the StockValueFinder evaluation, explaining what the numbers mean, what ranges are typically considered strong or weak, and why STIM passed or failed each test. By the end, readers should have a clearer understanding of how to assess these metrics in other stocks as well.
Why the StockValueFinder Score Matters
The StockValueFinder score is a composite metric designed to evaluate a company’s financial health, efficiency, and valuation discipline. The score ranges from 0% to 100%, with higher scores indicating a stronger overall profile based on the system’s criteria. A score of 43% for STIM places it in the lower half of the scoring range, leading to an "AVOID" rating.
This score is not a prediction of future stock performance. Instead, it reflects how well the company meets StockValueFinder’s standards for earnings consistency, capital efficiency, financial safety, and valuation. A low score does not mean the stock will decline, nor does a high score guarantee future gains. It simply provides a structured way to compare companies based on fundamental metrics.
For context, StockValueFinder generally considers scores above 70% as potentially attractive, scores between 50% and 70% as neutral or mixed, and scores below 50% as weaker profiles that may carry higher risk. STIM’s 43% score falls into the latter category, indicating that the company has not met several key financial benchmarks.
EPS Strength and Consistency
What Is EPS?
Earnings per share (EPS) measures a company’s profitability on a per-share basis. It is calculated by dividing net income by the number of outstanding shares. EPS is a critical metric because it shows how much money a company generates for each share of its stock. Consistency in EPS is important because it suggests stable business performance, while erratic EPS may indicate volatility or operational challenges.
Why EPS Consistency Matters
StockValueFinder evaluates EPS consistency to assess whether a company can reliably generate earnings over time. Companies with steady or growing EPS are often viewed as more stable investments, while those with declining or highly variable EPS may pose higher risks.
StockValueFinder’s EPS Test
StockValueFinder’s system includes an EPS test to screen for companies with a history of consistent or improving earnings. The exact criteria for passing this test are not provided in the supplied facts, but the system recorded that STIM **did not pass** the EPS test.
Since the exact EPS values are not supplied, we cannot analyze the specific earnings history. However, the failure of this test suggests that STIM’s earnings have not met the system’s standards for consistency or growth. For example, if a company’s EPS fluctuated between positive and negative values over the past few years, it would likely fail this test. In contrast, a company with steadily increasing EPS (e.g., $1.00, $1.20, $1.40 over three years) would be more likely to pass.
Educational Takeaway
When evaluating EPS for other stocks, look for a pattern of stability or growth. A single year of strong earnings is less meaningful than a multi-year trend. For instance, if Company A reports EPS of $0.50, $0.60, and $0.70 over three years, it demonstrates consistent growth. If Company B reports EPS of $0.50, -$0.20, and $0.80, it may fail an EPS consistency test due to volatility.
ROIC and Capital Efficiency
What Is ROIC?
Return on invested capital (ROIC) measures how effectively a company uses its capital to generate profits. It is calculated as:
**ROIC = (Net Operating Profit After Tax) / (Total Invested Capital)**
ROIC is expressed as a percentage and indicates how well a company allocates its resources. A higher ROIC suggests that the company is generating more profit from each dollar of invested capital.
Why ROIC Matters
ROIC is a key indicator of capital efficiency. Companies with high ROIC are often better at deploying capital to generate returns, which can lead to stronger long-term performance. In contrast, a low or negative ROIC may signal inefficiency or poor capital allocation.
StockValueFinder’s ROIC Benchmark
StockValueFinder generally prefers companies with an ROIC of **10% or higher**. This threshold is based on the idea that a company should generate returns above its cost of capital to create value for shareholders.
STIM’s ROIC
Neuronetics Inc has an ROIC of **-34.61%**. This negative value indicates that the company is not generating sufficient returns on its invested capital. In fact, it is losing money on its investments, which is a red flag for capital efficiency.
For comparison, a company with a 15% ROIC is typically using its capital more effectively than one with a 4% ROIC. A negative ROIC, like STIM’s, suggests that the company’s operations are not covering the cost of its capital, which could lead to financial strain over time.
Why STIM Failed the ROIC Test
Given that StockValueFinder’s benchmark is 10% or higher, STIM’s ROIC of -34.61% falls far below the acceptable range. This is why the system recorded a **fail** for the ROIC test.
Educational Takeaway
When evaluating ROIC for other stocks, aim for companies with ROIC above 10%. For example: - A company with 12% ROIC is generally more efficient than one with 5% ROIC. - A negative ROIC, like STIM’s, is a warning sign that the company may be struggling to generate returns on its investments.
Interest Coverage and Financial Safety
What Is Interest Coverage?
Interest coverage is a financial ratio that measures a company’s ability to pay the interest on its debt. It is calculated as:
**Interest Coverage = (Earnings Before Interest and Taxes) / (Interest Expense)**
The ratio shows how many times a company’s earnings can cover its interest payments. A higher interest coverage ratio indicates stronger financial health, while a low ratio may signal difficulty in meeting debt obligations.
Why Interest Coverage Matters
Interest coverage is a critical metric for assessing financial safety. Companies with low or negative interest coverage may struggle to service their debt, which can lead to financial distress or even bankruptcy. In contrast, companies with high interest coverage ratios are better positioned to handle economic downturns or unexpected expenses.
StockValueFinder’s Interest Coverage Benchmark
StockValueFinder generally prefers companies with an interest coverage ratio of **6 or higher**. This threshold ensures that the company has a comfortable margin to cover its interest payments.
STIM’s Interest Coverage
The supplied facts indicate that STIM **did not pass** the interest coverage test. While the exact interest coverage ratio is not provided, the failure of this test suggests that the company’s earnings are insufficient to cover its interest expenses comfortably.
For example
Educational Takeaway
When evaluating interest coverage for other stocks, look for ratios of 6 or higher. For instance: - A ratio of 10x is strong and indicates financial safety. - A ratio below 3x is risky and may signal potential financial trouble.
Debt Payback and Balance Sheet Discipline
What Is Debt Payback?
Debt payback measures how long it would take a company to pay off its total debt using its current cash flow. It is calculated as:
**Debt Payback (Years) = (Total Debt) / (Free Cash Flow)**
A shorter debt payback period indicates stronger financial health, as the company can quickly eliminate its debt burden. A longer period may signal higher financial risk.
Why Debt Payback Matters
Debt payback is a key indicator of balance sheet discipline. Companies with shorter debt payback periods are generally better positioned to weather economic downturns, invest in growth opportunities, or return capital to shareholders. In contrast, companies with long debt payback periods may face higher financial risk, especially if cash flow declines.
StockValueFinder’s Debt Payback Benchmark
StockValueFinder generally prefers companies with a debt payback period of **3 years or less**. This threshold ensures that the company can quickly reduce its debt burden and maintain financial flexibility.
STIM’s Debt Payback
Neuronetics Inc has a debt payback period of **-3.11 years**. The negative value indicates that the company is not generating positive free cash flow, making it impossible to calculate a meaningful debt payback period. However, the system recorded that STIM **passed** the debt payback test.
This may seem counterintuitive, but StockValueFinder’s system likely treats negative debt payback as a pass because the company has no meaningful debt to repay in the near term. Alternatively, the system may prioritize other factors, such as low absolute debt levels, over the negative cash flow.
Educational Takeaway
When evaluating debt payback for other stocks, aim for a period of 3 years or less. For example: - A company with a debt payback period of 1.5 years is in a strong position. - A company with a period of 7 years may face higher financial risk.
P/E Ratio and Valuation Discipline
What Is the P/E Ratio?
The price-to-earnings (P/E) ratio measures a company’s stock price relative to its earnings per share. It is calculated as:
**P/E Ratio = (Stock Price) / (Earnings Per Share)**
The P/E ratio helps investors assess whether a stock is overvalued or undervalued relative to its earnings. A lower P/E ratio may indicate a more attractively priced stock, while a higher P/E ratio may suggest that the stock is expensive relative to its earnings.
Why the P/E Ratio Matters
The P/E ratio is a key valuation metric because it provides insight into how much investors are willing to pay for each dollar of earnings. Companies with low P/E ratios may be undervalued, while those with high P/E ratios may be overvalued or expected to grow rapidly.
StockValueFinder’s P/E Benchmark
StockValueFinder generally prefers companies with a P/E ratio of **15 or lower**. This threshold is based on the idea that a lower P/E ratio may indicate better value, assuming the company’s earnings are stable and sustainable.
STIM’s P/E Ratio
Neuronetics Inc has a P/E ratio of **-3.58**. The negative value indicates that the company is currently unprofitable, as it is reporting negative earnings per share. Despite this, the system recorded that STIM **passed** the P/E valuation test.
This may seem unusual, but StockValueFinder’s system likely treats negative P/E ratios as a pass because the company’s stock price is low relative to its earnings (or lack thereof). In other words, the system may prioritize the absolute valuation over the profitability of the business.
Educational Takeaway
When evaluating P/E ratios for other stocks, aim for values of 15 or lower for value-oriented investments. For example: - A P/E ratio of 8 may indicate an undervalued stock, assuming the business is sound. - A P/E ratio of 40 may indicate an overvalued stock or high growth expectations.
Moving Average Trend and Entry Timing
What Is a Moving Average?
A moving average is a technical indicator that smooths out price data by calculating the average price of a stock over a specific period (e.g., 50 days or 200 days). Moving averages help investors identify trends and potential entry or exit points.
Why Moving Averages Matter
Moving averages are used to assess the trend of a stock’s price. A stock trading above its moving average may be in an uptrend, while a stock trading below its moving average may be in a downtrend. Moving averages can also act as support or resistance levels.
STIM’s Moving Average Signal
Neuronetics Inc has a moving average signal of **NEUTRAL / WATCH**. This indicates that the stock’s price is not clearly trending above or below its moving averages, making it difficult to determine a strong directional bias. The system also recorded an **entry signal of N/A**, meaning there is no clear buy or sell signal based on the moving average trend.
Educational Takeaway
When evaluating moving averages for other stocks, consider the following
Overall Financial Strengths and Weaknesses
Strengths
1. **Passed the Debt Payback Test**: While STIM’s debt payback period is negative, the system recorded a pass for this test. This may indicate that the company has low absolute debt levels or other mitigating factors. 2. **Passed the P/E Valuation Test**: Despite reporting negative earnings, STIM’s low stock price relative to its earnings (or lack thereof) resulted in a pass for the P/E valuation test.
Weaknesses
1. **Failed the EPS Test**: STIM did not pass the EPS consistency test, suggesting that its earnings have been volatile or declining. 2. **Failed the ROIC Test**: With an ROIC of -34.61%, STIM is not generating sufficient returns on its invested capital, indicating poor capital efficiency. 3. **Failed the Interest Coverage Test**: The company’s inability to pass this test suggests that it may struggle to cover its interest payments, posing a financial risk. 4. **Neutral Moving Average Signal**: The lack of a clear trend may make it difficult to time an entry or exit based on technical analysis.
Risks and Limitations
Financial Risks
1. **Negative Earnings and ROIC**: STIM’s negative earnings and ROIC indicate that the company is not profitable and is losing money on its investments. This poses a significant financial risk, as the company may struggle to sustain operations without external funding. 2. **Interest Coverage Concerns**: The failure of the interest coverage test suggests that STIM may have difficulty servicing its debt, which could lead to financial distress. 3. **Low Stock Price**: At $2.11 per share, STIM’s stock price is already low, which may limit further downside but also reflects investor skepticism about the company’s prospects.
Industry Risks
1. **Medical Devices Sector**: The medical devices industry is highly competitive and subject to regulatory scrutiny. Companies in this sector often face high research and development costs, long product approval timelines, and pricing pressures. 2. **Healthcare Sector Volatility**: The healthcare sector can be volatile due to changes in government policies, insurance reimbursement rates, and technological advancements. Companies like STIM may face challenges in maintaining profitability amid these shifts.
Limitations of This Analysis
1. **Incomplete Data**: This article is based solely on the supplied facts from StockValueFinder.com. Additional data, such as detailed earnings history, cash flow statements, or industry comparisons, could provide further context. 2. **No Future Predictions**: This analysis does not predict future stock performance or company success. It is based on historical and current financial metrics. 3. **No Personal Financial Advice**: This article is for educational purposes only and does not constitute financial advice or a recommendation to buy or sell STIM.
Educational Conclusion
This educational review of Neuronetics Inc (STIM) has walked through the key financial metrics used by StockValueFinder to evaluate stocks. By analyzing each metric—EPS consistency, ROIC, interest coverage, debt payback, P/E ratio, and moving average trend—readers can better understand how to assess a company’s financial health and valuation.
Key Takeaways for Evaluating Stocks
1. **EPS Consistency**: Look for stable or growing earnings over time. Volatile or declining EPS may indicate higher risk. 2. **ROIC**: Aim for companies with ROIC of 10% or higher. Negative ROIC, like STIM’s, is a warning sign of poor capital efficiency. 3. **Interest Coverage**: Prefer companies with interest coverage of 6 or higher. Low or negative coverage may signal financial distress. 4. **Debt Payback**: Shorter debt payback periods (3 years or less) indicate stronger balance sheet discipline. 5. **P/E Ratio**: Lower P/E ratios (15 or below) may indicate better value, assuming the business is sound. 6. **Moving Average Trend**: Use moving averages to assess trends, but remember that they are not guarantees of future performance.
Final Thoughts on STIM
Neuronetics Inc’s StockValueFinder score of 43% and "AVOID" rating reflect its struggles with profitability, capital efficiency, and financial safety. While the company passed the debt payback and P/E valuation tests, its negative earnings, ROIC, and interest coverage raise significant concerns. Investors should carefully consider these risks and conduct further research before making any decisions.
This article is for research and educational purposes only. It is not personal financial advice, investment advice, or a recommendation to buy or sell any security. Always conduct your own due diligence and consult with a financial advisor before making investment decisions.
Research links: Yahoo Finance | Seeking Alpha | Finviz | SEC Filings
30-Day Trendline Analysis
Optional intraday chart with rising support, falling resistance, and multi-timeframe views.